N-bromobutanimide → HCID 23298010、化合物
反応式
[Br:1][C:2]1[CH:11]=[C:10]2[C:5]([N:6]=[C:7]([O:14][CH3:15])[C:8]([O:12][CH3:13])=[N:9]2)=[C:4]([CH3:16])[CH:3]=1.[Br:17]N1C(=O)CCC1=O>C(Cl)(Cl)(Cl)Cl>[Br:1][C:2]1[CH:11]=[C:10]2[C:5]([N:6]=[C:7]([O:14][CH3:15])[C:8]([O:12][CH3:13])=[N:9]2)=[C:4]([CH2:16][Br:17])[CH:3]=1参加物
4
実験手順
15 g (53 mmol) of 7-bromo-5-methyl-2,3-dimethoxy-quinoxaline, 9.9 g (1.05 equiv.) of N-bromosuccinimide and 0.87 g (0.1 equiv.) of azo-isobutyronitrile are dissolved in 100 ml of carbon tetrachloride and the solution is stirred at reflux for 24 hours. The solid is filtered off and the filtrate is diluted with dichloromethane, then washed once with each of water and brine. The organic phase is dried over magnesium sulfate and concentrated by evaporation. The residue is recrystallized from ethyl acetate and hexane. The title compound is obtained in the form of light-orange crystals.
後処理
- temperatureat reflux for 24 hours
- filtrationThe solid is filtered off
- additionthe filtrate is diluted with dichloromethane
- washwashed once with each of water and brine
- dry with materialThe organic phase is dried over magnesium sulfate
- concentrationconcentrated by evaporation
- customThe residue is recrystallized from ethyl acetate and hexane
出典と根拠
- ORDレコード
- ord-94c68e858ea046f886de8dc83e034cfe
- 出典データセット
- uspto-grants-2000_06
- 特許番号
- US06080743
反応ノート
読み込み中…